Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes

Int J Hyperthermia. 2020;37(1):938-943. doi: 10.1080/02656736.2020.1766122.

Abstract

Purpose: To evaluate the safety and effect of microwave ablation (MWA) compared with transcatheter arterial embolization (TAE) for the treatment of large hepatic hemangiomas.

Materials and methods: A total of 135 patients with symptomatic or/and enlarging hepatic hemangiomas (5-10 cm) from two centers underwent either MWA (n = 82) or TAE (n = 53) as first-line treatment. We compared the two groups in terms of radiologic response, clinical response, operative time, postoperative analgesic requirements, hospital stay and complications.

Results: MWA had a significantly higher rate of complete radiologic response (89.0% vs. 37.7%, p<.001) and complete clinical response (88.6% vs. 69.2%, p=.046), fewer minor complications (43.9% vs. 66.0%, p=.019), shorter time of using analgesics (p<.001) and shorter hospital stays (p=.003) than did TAE. The operative time and major complications were comparable between the two groups.

Conclusion: Both MWA and TAE are safe and effective in treating patients with large hepatic hemangiomas. MWA had a higher rate of complete response than did TAE, and it was associated with fewer minor complications, faster recovery and shorter hospital stay.

Keywords: Hepatic hemangioma; microwave ablation; transcatheter arterial embolization; retrospective study; clinical outcomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Catheter Ablation*
  • Embolization, Therapeutic*
  • Hemangioma* / diagnostic imaging
  • Hemangioma* / surgery
  • Humans
  • Liver Neoplasms* / surgery
  • Liver Neoplasms* / therapy
  • Microwaves / therapeutic use
  • Treatment Outcome